Business
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Advertisement
Topic
Outlook
Business
Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates
Business
Pfizer hikes full-year outlook on new product growth, taps company veteran as new CFO
Pfizer announced that Cecile Guegan, who has held various leadership roles at the company over the last 20 years, stepped in as CFO this month.